Mean CHA2DS2-VASc scorea (SD) | 3.6 (1.6) | 4.0 (1.5) | 3.9 (1.5) |
CHA2DS2-VASc score 1, n (%) | 3 (10.7) | 6 (6.3) | 3 (2.6) |
Female, n (%) | 15 (53.6) | 51 (53.7) | 71 (60.7) |
CHA2DS2-VASc score 2 in females, n (%) | 0 (0.0) | 4 (7.8) | 8 (11.3) |
|
Initiation of anticoagulant treatment,b n (%) | | | |
VKA | 18 (64.3) | 45 (47.4) | 68 (58.1) |
NOAC | 5 (17.9) | 41 (43.2) | 34 (29.1) |
Antiplatelet | 0 (0.0) | 1 (1.1) | 4c (3.4) |
|
Details about anticoagulant treatment, n (%) | | | |
According to guidelinesd | 26 (92.9) | 89 (93.7) | 106 (90.6) |
Intended deviation from guidelinese | 1 (3.6) | 4 (4.2) | 5 (4.3) |
Unintended deviation from guidelinesf | 1 (3.6) | 2 (2.1) | 6 (5.1) |